Ratan Capital Management LP Bridge Bio Pharma, Inc. Transaction History

Ratan Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$11.38 - $53.41 $341,400 - $1.6 Million	-30,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$46.87 - $64.24 $2.23 Million - $3.06 Million	-47,600 Reduced 61.34%	30,000 $1.41 Million
Q2 2021 Aug 16, 2021	SELL	$46.47 - $63.93 $288,160 - $396,429	-6,201 Reduced 7.4%	77,600 $4.73 Million
Q1 2021 May 21, 2021	BUY	$55.47 - $72.35 $3.95 Million - $5.15 Million	71,201 Added 565.09%	83,801 $5.16 Million
Q2 2020 Aug 14, 2020	SELL	$22.22 - $35.69 $119,988 - $192,726	-5,400 Reduced 30.0%	12,600 $411,000
Q4 2019 Feb 14, 2020	SELL	$17.96 - $46.63 $512,722 - $1.33 Million	-28,548 Reduced 61.33%	18,000 $631,000
Q3 2019 Nov 14, 2019	SELL	$20.13 - $32.38 $270,788 - $435,575	-13,452 Reduced 22.42%	46,548 $999,000
Q2 2019 Aug 14, 2019	BUY	$26.97 - $27.55 $1.62 Million - $1.65 Million	60,000 New	60,000 $1.62 Million

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.47B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Ratan Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Ratan Capital Management LP with notifications on news.